GSF4B inhibitors, also known as Immunoglobulin Superfamily Member 4B inhibitors, represent a class of chemical compounds designed to modulate the activity of the IGSF4B protein. IGSF4B, short for Immunoglobulin Superfamily Member 4B, is a cell surface glycoprotein that belongs to the immunoglobulin superfamily. This protein is primarily found in various tissues, including the nervous system, where it plays a crucial role in cell adhesion and signaling processes. IGSF4B is characterized by its extracellular immunoglobulin-like domains, which are involved in protein-protein interactions. Its presence at cell-cell contact sites implies its involvement in cell adhesion and cell signaling pathways. Consequently, IGSF4B has garnered significant attention in the field of cellular biology and has been studied for its role in various physiological and pathological processes.
IGSF4B inhibitors are designed to selectively target and modulate the function of IGSF4B. These chemical compounds can either block or enhance the interactions involving IGSF4B, depending on their specific mechanisms of action. By doing so, IGSF4B inhibitors can influence cellular adhesion, communication, and signaling events. Researchers are keen on exploring the precise mechanisms through which these inhibitors affect IGSF4B function and their implications in various cellular processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K, which is involved in the signaling pathways where IGSF4B may play a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Another PI3K inhibitor, potentially reducing the downstream effects mediated by IGSF4B. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which is upstream of ERK, potentially affecting IGSF4B-related signaling. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which can regulate processes that IGSF4B is speculated to be involved in. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, potentially altering IGSF4B-related cellular responses. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2, potentially affecting IGSF4B-driven cellular dynamics. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, which could alter cell survival and differentiation pathways involving IGSF4B. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
Src family kinase inhibitor, which could modify IGSF4B-related signaling. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which can indirectly influence IGSF4B-associated cellular mechanisms. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $63.00 $114.00 $218.00 $349.00 | 74 | |
EGFR inhibitor, could affect cellular pathways where IGSF4B is relevant. | ||||||